Chronic Obstructive Pulmonary Disease Clinical Trial
— EUROPTOfficial title:
A Multi-Center, Prospective, Clinical Trial Designed to Study the Efficacy of One-Way Valve Implantation Based on a New Treatment Algorithm in Patients With Heterogeneous Emphysema
The purpose of this study is to assess the efficacy of a new treatment algorithm for bronchoscopic lung volume reduction (BLVR) in patients with emphysema based on the information of emphysema heterogeneity, destruction score, and fissure analysis.
Status | Unknown status |
Enrollment | 20 |
Est. completion date | |
Est. primary completion date | September 2008 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patient diagnosed by HRCT Core Lab with eligible heterogeneous disease distribution and at least one complete oblique fissure. - Age from 40 to 75 years - BMI < 32 kg/m2 - FEV1 < 40% of predicted value, FEV1/FVC < 70% - TLC > 120% predicted, RV > 150% predicted. - Stable with < 20 mg prednisone (or equivalent) qd - PaCO2 < 50mm Hg - PaO2 > 45 mm Hg on room air - 6-min walk of > 50m (without rehabilitation) or > 100m (with rehabilitation) - Nonsmoking for 4 months prior to initial interview and throughout screening - The patient agrees to all protocol required follow-up intervals. - The patient has no child bearing potential - The patient is willing and able to complete protocol required baseline assessments and procedures Exclusion Criteria: - Prior endobronchial treatment for emphysema - Pleural or interstitial disease that precludes surgery. - Prior lung transplant, LVRS, median sternotomy, bullectomy or lobectomy. - Clinically significant bronchiectasis - Pulmonary nodule requiring surgery - History of recurrent respiratory infections (> 3 hospitalization in the last year) - Clinically significant (> 4 Tablespoons per day) sputum production - Fever, elevated white cell count, or other evidence of active infection - Dysrhythmia that might pose a risk during exercise or training - Congestive heart failure within 6 mo and LVEF < 45% - Evidence or history of Cor Pulmonale - Resting bradycardia (< 50 beats/min), frequent multifocal PVCs, complex ventricular arrhythmia, sustained SVT - History of exercise-related syncope - MI within 6 mo and LVEF < 45% - Evidence of systemic disease or neoplasia expected to compromise survival during 5-yr period - Any disease or condition that interferes with completion of initial or follow-up assessments - Patient is currently enrolled in another clinical trial - Patient is unable to complete 3 minutes of unloaded peddling on cycle ergometer - Alpha-1-Antitrypsin Deficiency |
Country | Name | City | State |
---|---|---|---|
Austria | Otto Wagner Hospital | Vienna | |
Belgium | University Antwerp | Antwerp | |
Belgium | University Brussels | Brussels |
Lead Sponsor | Collaborator |
---|---|
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology |
Austria, Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean % change in lung function (FEV1) | 90 days post index bronchoscopic lung volume reduction | ||
Secondary | Mean % change in target lobe Residual Volume and Total Lung Capacity. Mean absolute change in dyspnea (mMRC-Score), Quality of life using St. George's Respiratory Questionnaire and SF-36. | 90 days post-index bronchoscopic lung volume reduction |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|